FDA Opens AI Medical Device Review for Public Feedback

The U.S. Food and Drug Administration has opened a public consultation on how generative artificial intelligence-enabled medical devices should be regulated, seeking feedback on risk assessment, premarket evaluation and postmarket monitoring. The FDA said the discussion paper is intended to help shape an approach that supports patient safeguards while allowing innovation in digital health…